Vimarsana
Biggest News Aggregation in the World

Page 5 - Andreas Wolf News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andreas Wolf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andreas Wolf Today - Breaking & Trending Today

AMADEUS FIRE AG : Receives a Buy rating from Warburg Research -February 15, 2024 at 06:18 am EST - Vimarsana News

AMADEUS FIRE AG : Receives a Buy rating from Warburg Research -February 15, 2024 at 06:18 am EST

Andreas Wolf from Warburg Research retains his positive opinion on the stock with a Buy rating. The target price remains unchanged at EUR 180.

Warburg Research rates Cancom a 'Buy' - Target 40 euros - Vimarsana News

Warburg Research rates Cancom a 'Buy' - Target 40 euros

The analyst firm Warburg Research has left the rating for Cancom at Buy with a target price of 40 euros after preliminary quarterly figures. Sales were slightly better than forecast, but the operating...

NEMETSCHEK AG : Warburg Research sticks Neutral -February 08, 2024 at 04:32 am EST - Vimarsana News

NEMETSCHEK AG : Warburg Research sticks Neutral -February 08, 2024 at 04:32 am EST

Warburg Research analyst Andreas Wolf maintains his Neutral opinion on the stock. The target price remains unchanged at EUR 69.

COMPUGROUP MEDICAL : Warburg Research maintains a Buy rating -February 08, 2024 at 04:32 am EST - Vimarsana News

COMPUGROUP MEDICAL : Warburg Research maintains a Buy rating -February 08, 2024 at 04:32 am EST

In a research note published by Andreas Wolf, Warburg Research advises its customers to buy the stock. The target price is lowered from EUR 70 to EUR 65.

TEAMVIEWER : Warburg Research keeps its Buy rating -February 07, 2024 at 05:23 am EST - Vimarsana News

TEAMVIEWER : Warburg Research keeps its Buy rating -February 07, 2024 at 05:23 am EST

In a research note, Warburg Research analyst Andreas Wolf has maintained his recommendation on the stock with a Buy rating. The target price is unchanged and still at EUR 18.50.